Dr. Kanwal Raghav

About Dr. Kanwal Raghav

Kanwal Raghav is an experienced medical oncologist who provides cancer care for patients facing mesothelioma and other difficult-to-treat diseases.

He practices at MD Anderson Cancer Center in Texas, one of the nation’s leading centers for mesothelioma treatment and cancer research. There, he works with multidisciplinary specialists to care for patients with complex diagnoses, such as peritoneal mesothelioma.

Dr. Raghav is well known for his research into immunotherapy and molecular profiling, a type of testing that helps doctors better understand how a patient’s cancer may respond to certain treatments. His studies have helped identify biomarkers that guide treatment plans for mesothelioma patients.

His goal is to help patients access therapies that may improve survival, reduce symptoms, and support a better quality of life.

Use our Free Doctor Match to connect with Dr. Raghav and learn more about mesothelioma treatment options in Texas.

What Health Conditions Does Dr. Kanwal Raghav Treat?

Dr. Raghav treats a wide range of cancers, particularly those affecting the gastrointestinal system and abdominal cavity.

His primary areas of focus include:

• Peritoneal mesothelioma: A rare cancer affecting the abdominal lining
• Colorectal cancer: Including advanced-stage disease
• Pancreatic cancer and gastric cancer: Complex gastrointestinal cancers
• Other neoplasms and carcinoma types: Including adenocarcinoma

He works closely with specialists to ensure each patient receives coordinated cancer treatment tailored to their diagnosis.

Dr. Kanwal Raghav’s Approach to Mesothelioma Treatment

Kanwal Raghav, MD, focuses on advancing mesothelioma treatment through research-driven care and innovative therapies.

He can use mesothelioma treatments like:

• Chemotherapy: Using cancer-fighting drugs to slow tumor growth and help manage mesothelioma symptoms
• Immunotherapy: Using medications like pembrolizumab, nivolumab, and atezolizumab to help the immune system find and destroy cancer cells
• Targeted therapies: Using molecular profiling and biomarker testing to identify specific changes in cancer cells, and incorporating medications like bevacizumab
• Clinical trials: Connecting cancer patients with newer treatments offered in trials for unresectable (inoperable) mesothelioma

He evaluates each patient’s performance status, disease stage, and treatment goals to determine the most effective plan. His work often focuses on improving overall survival and expanding treatment options.

Download our Free Checklist of Questions to Ask Your Doctor to help prepare for appointments with Dr. Raghav and other mesothelioma specialists.

Dr. Kanwal Raghav’s Medical Background

Dr. Raghav has an extensive international and academic background in oncology and internal medicine.

He earned his MBBS from Delhi University College of Medical Sciences and also studied at the University of Arkansas for Medical Sciences College of Medicine.

He completed his residency in internal medicine at Albert Einstein Healthcare Network, followed by a fellowship in hematology and medical oncology at The University of Texas Health Science Center at Houston/MD Anderson Cancer Center.

Work Experience

Dr. Raghav has spent years treating patients with advanced cancers while also helping develop newer therapies through clinical studies and collaborative oncology programs.

His experience includes:

• Associate professor at The University of Texas MD Anderson Cancer Center in Houston
• Clinical and research roles in medical oncology and hematology
• Collaboration with leading oncology researchers, including Overman and Varadhachary
• Contributions to national and international cancer research efforts
• Participation in major clinical trials focused on gastrointestinal cancers and mesothelioma

His experience in patient care and clinical research allows him to help bring emerging treatments into real-world care for those fighting mesothelioma.

Highlights of Dr. Kanwal Raghav’s Medical Career

Dr. Raghav has built a strong reputation in oncology for his work in cancer treatment, clinical research, and personalized patient care.

His experience in mesothelioma and gastrointestinal cancers has led to leadership roles, professional collaborations, and involvement with nationally recognized medical organizations.

Some of his professional highlights include:

• Active medical licenses across multiple states
• Associate Professor at MD Anderson Cancer Center
• Certification by the American Board of Internal Medicine in medical oncology
• Involvement with the American Association for Cancer Research (AACR)
• Membership in the American Society of Clinical Oncology (ASCO)
• Participation in gastrointestinal oncology research
• Work with multidisciplinary cancer treatment initiatives

His continued involvement in cancer organizations and collaborative programs helps support advancements in immunotherapy, biomarker testing, and emerging treatment strategies for mesothelioma patients.

Dr. Kanwal Raghav’s Work in Cancer Treatment & Clinical Trials

Dr. Raghav helps lead clinical trials for mesothelioma and other aggressive cancers at MD Anderson Cancer Center. His focus is on helping patients access newer therapies when standard treatments may no longer be effective.

His areas of focus include:

• Developing new strategies designed to improve mesothelioma survival rates
• Evaluating molecular profiling to help guide personalized treatment
• Researching treatments for patients who don’t qualify for surgery
• Studying atezolizumab and bevacizumab for advanced peritoneal mesothelioma
• Testing immunotherapy drugs that help the immune system attack cancer cells

These efforts have helped expand treatment options for patients with rare cancers and improve access to promising therapies through clinical trials.

“These diseases can be different even at a molecular level, which is why patients need specialized care and research.”
– Dr. Kanwal Raghav, mesothelioma specialist

Dr. Kanwal Raghav’s Cancer Research and Published Works

Dr. Raghav has contributed to important research focused on mesothelioma and gastrointestinal cancers.

Some of his published works include:

• Utility of Gene Expression–Based Cancer Classification in Diagnosis of Malignant Peritoneal Mesothelioma (MPeM): Filling in the Gaps in Standard Pathologic Work-Up for a Rare Cancer. Published in Journal of Clinical Oncology, January 2024.
• Clinical Efficacy of Immune Checkpoint Inhibitors in Advanced Malignant Peritoneal Mesothelioma. Published in Cancer Medicine, June 2021.
• Phase II Trial of Treatments for Malignant Peritoneal Mesothelioma. Published in JAMA Oncology, September 2021.
• Malignant Peritoneal Mesothelioma in Women: A Clinicopathologic Study. Published in The American Journal of Surgical Pathology, March 2020.

His research continues to shape how mesothelioma and related cancers are understood and treated.

Use our Free Doctor Match to connect with Dr. Raghav for expert guidance on today’s latest mesothelioma treatments and clinical trials.

Connect With Dr. Kanwal Raghav at MD Anderson Cancer Center

A mesothelioma diagnosis can bring uncertainty about treatment options, next steps, and where to find specialized care. Working with an experienced mesothelioma doctor can help patients better understand their options and feel more confident about treatment decisions.

Dr. Kanwal Raghav is known for his research-driven approach to cancer care and his work developing newer therapies for mesothelioma patients. At MD Anderson Cancer Center, he helps patients explore personalized treatment plans, immunotherapy, and clinical trial options.

At Mesothelioma Hope, we connect patients and families with leading mesothelioma specialists, cancer centers, and support resources.

If you or a loved one has been affected by mesothelioma, our Patient Advocates are here for you. Call (866) 608-8933 or use our Free Doctor Match to connect with Dr. Raghav and learn more about starting treatment.